Is the FDA “doubling down” on a failed strategy?

By Maryanne Demasi, PhD | January 30, 2023 Last Thursday, the FDA convened its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss the future of covid vaccines. The panel voted 21 to 0 in favour of moving towards a more simplified vaccine schedule – an annual shot which would be updated as new variants emerge – […]

Source